Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Standardized Fecal Microbiota Transplantation for Moderate to Severe Crohn&Apos;s Diseases

NCT01793831 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.

NCT NCT01793831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01793831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Standardized Fecal Microbiota Transplantation for Moderate to Severe Crohn&Apos;s Diseases
Lead sponsor
The Second Hospital of Nanjing Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
February 28, 2013
Completion date
December 31, 2025
Enrollment
800 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease (cd), inflammatory bowel disease